000 | 01595 a2200433 4500 | ||
---|---|---|---|
005 | 20250515010632.0 | ||
264 | 0 | _c20061211 | |
008 | 200612s 0 0 eng d | ||
022 | _a0021-9150 | ||
024 | 7 |
_a10.1016/j.atherosclerosis.2005.10.037 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTremblay, André J | |
245 | 0 | 0 |
_aEffects of fenofibrate on apolipoprotein kinetics in patients with coexisting dysbetalipoproteinemia and heterozygous familial hypercholesterolemia. _h[electronic resource] |
260 |
_bAtherosclerosis _cSep 2006 |
||
300 |
_a203-12 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aApolipoprotein A-I _xblood |
650 | 0 | 4 |
_aApolipoprotein B-100 _xblood |
650 | 0 | 4 |
_aApolipoprotein B-48 _xblood |
650 | 0 | 4 |
_aApolipoproteins _xblood |
650 | 0 | 4 |
_aFenofibrate _xtherapeutic use |
650 | 0 | 4 | _aHeterozygote |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHyperlipoproteinemia Type II _xcomplications |
650 | 0 | 4 |
_aHyperlipoproteinemia Type III _xcomplications |
650 | 0 | 4 |
_aHypolipidemic Agents _xtherapeutic use |
650 | 0 | 4 | _aKinetics |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aTriglycerides _xblood |
700 | 1 | _aLamarche, Benoît | |
700 | 1 | _aRuel, Isabelle L | |
700 | 1 | _aHogue, Jean-Charles | |
700 | 1 | _aDeshaies, Yves | |
700 | 1 | _aGagné, Claude | |
700 | 1 | _aCouture, Patrick | |
773 | 0 |
_tAtherosclerosis _gvol. 188 _gno. 1 _gp. 203-12 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.atherosclerosis.2005.10.037 _zAvailable from publisher's website |
999 |
_c15958418 _d15958418 |